Skip to content

Targets

  • Innovative medtech SME based in Soleto, in Apulia, developing multi-articulated hand prostheses.
  • Adam’s Hand is a myoelectric prosthesis allowing fingers’ movement, adapting to the shape and size of the objects being grasped.
  • Startup founded in 2018 as a spin-off of the University of Palermo (Sicily). It develops medical devices, therapies, and digital clinical protocols in the field of neurorehabilitation using non-invasive methods.
  • MindLenses is a device treating cognitive deficits using prismatic lenses and rehabilitation protocols based on Serious Games.
  • Innovative SME founded in 2009 in Milan. It has developed YntraDose, an implantable medical device aimed to deliver "precision radiotherapy from within".
  • YntraDose emits therapeutic radiation capable of targeting and destroying cancer cells precisely in inoperable tumor cases such as liver, pancreas, and breast.
  • Innovative SME founded in 2014 in Milan, operating in the design and development of See.d, in vitro product for oncological diagnostics.
  • The device covers the complete diagnostic workflow, from sample preparation to analytical results of liquid biopsy samples in early cancer detection (prostate and breast).
  • Innovative startup founded in early 2020 in Turin. It collaborates with the Polytechnic University of Turin and the Cancer Prevention Foundation of Candiolo.
  • It developed AI-based technologies to improve cancer prevention (breast and prostate). Breast.ai and Prostate.ai optimize screening and diagnostics, enabling early disease detection through imaging biopsy.
  • Innovative startup founded in 2021 as a spin-off from the Italian Institute of Technology in Genoa.
  • It developed treatment for neurological diseases. Conducting preclinical trials for symptoms related to Down syndrome, autism spectrum disorders, epilepsy, and rare neurodevelopmental diseases. A drug for the treatment of autism is undergoing trials with promising outcomes.
  • Startup founded in 2020 as a spin-off of the Polytechnic University of Milan. It promotes the development and validation of therapeutic strategies for treating tricuspid regurgitation.
  • It developed an implantable medical device with minimally invasive implantation, consisting of a tricuspid valve repair system based on a ventricular remodeling approach.
  • Company founded in 2024 in Naples, serving as the Italian research center and operational hub of the Finnish company Valo Therapeutics Oy, coordinated by Prof. Vincenzo Cerullo.
  • It is developing innovative immuno-oncology drugs for the treatment of solid tumors (melanoma, lung cancer, breast cancer, etc.) and sarcomas. The drug is currently in Phase I clinical trials
  • Innovative SME based in Bresso (MI), working on textile technologies with surgical applications. It is developing a series of implantable scaffolds leveraging the natural properties of silk fibroin to promote the repair of certain human tissues.
  • The first product, SILKBridge, is a silk fibroin-based guide for the regeneration of peripheral nerve injuries. 
  • Company founded in 2008 as a spin-off of the IRCCS Ca’ Granda Foundation Ospedale Maggiore Policlinico and the University of Milan.
  • Develops a closed-loop Adaptive Deep Brain Stimulation (ADS) system, a fully implantable Class III active medical device designed for the primary indication of Parkinson's disease
  • VR Media S.r.l. is a deep-tech company (spin-off of the University of Pisa) that has developed Kiber, a comprehensive platform for AR (Augmented Reality) applications and remote collaboration, used by major industrial groups and international corporates.
  • Its advanced AR devices enable real-time interaction with data and personnel, improving processes such as diagnostics, maintenance, and remote training, and enabling faster, safer, and more reliable healthcare through advanced remote assistance.
  • VST S.r.l. – Vital Signals in a Touch is an innovative SME founded in 2017 as a spin-off from the University of Modena and Reggio Emilia. It developed medical devices to promote preventive healthcare across medical, wellness, and fitness sectors.
  • The company has developed three devices and one software solution (VSTFive): Ippocratech®, an integrated hardware-software system that measures five vital signs simultaneously—respiratory rate, heart rate, oxygen saturation, blood pressure, and ECG. The device also measures body temperature via infrared sensor. Welloopp, a wristband for athletes, and DCLIP, a device for monitoring non-cooperative patients (e.g., those with Alzheimer’s or Parkinson’s).
  • Innovative startup founded in 2019 and based in Trieste, operating as an ophthalmic medtech company to develop therapies and solutions for eye diseases.
  • It is developing Grosso Implant, the first minimally invasive intracorneal implant made of nitinol, capable of restoring the physiological curvature of the cornea to improve vision for patients suffering from keratoconus, a progressive eye disease causing visual distortions.
  • Innovative SME founded in 2015, which has developed and patented a UV-free LED sanitizing and lighting system (BIOVITAE), capable of continuous sanitization as it is safe for living organisms.
  • The company has launched Biovitae, a patented UV-free LED lamp structure for continuous sanitization. It plans to launch an industrial research center to develop additional proprietary patents for medical applications of the technology in various settings, including hospitals.
  • Biotechnology company, based in Modena, focused on the development, production and distribution of advanced therapeutic products composed by epithelial stem cell cultures for gene therapy.
  • It has developed products for life-saving therapy of eye burns and initiated the first gene therapy clinical trial for epidermolysis bullosa, a disabling genetic disease also known as “butterfly baby syndrome.”